COMMUNIQUÉS West-GlobeNewswire

Management Cease Trade Order Update
11/12/2018
HALIFAX, Nova Scotia, Dec. 11, 2018 (GLOBE NEWSWIRE) -- MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued [...]
Help Your Diabetes® Added To Franchise Dictionary’s Top 100 Game Changers As “One To Watch”
11/12/2018
GRAPEVINE, Texas, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Today, Help Your Diabetes®, a company that helps Type 2 Diabetics live diabetes-free lives through natural methods, announced that they have been voted into the Top [...]
NeoGenomics Announces Secondary Offering of Common Stock by Selling Stockholder
11/12/2018
FORT MYERS, Fla., Dec. 11, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced that GE Medical Systems Information Technologies, Inc [...]
Aeglea BioTherapeutics Announces Design of Pivotal Phase 3 PEACE Trial Evaluating Pegzilarginase in Arginase 1 Deficiency
11/12/2018
Single, Global Pivotal Trial to Support Registration; Primary Endpoint of Arginine Reduction Expected to Initiate in Q2 2019; Topline Data Anticipated in Q1 2021 Company to Host Conference Call Today at 5:00 p.m. ET [...]
Viveve Announces Closing of Public Offering of Shares of Common Stock
11/12/2018
ENGLEWOOD, Colo., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced the closing of its previously [...]
Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares
11/12/2018
JERSEY, Channel Islands, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the closing of its previously announced underwritten [...]
Momenta Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares
11/12/2018
CAMBRIDGE, Mass., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company with a validated scientific platform focused on discovering and developing novel therapeutics to [...]
Fluidigm Announces Commencement of Public Offering of Common Stock
11/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced that it intends to offer and sell, subject [...]
Amicus Therapeutics Awarded United Kingdom Prix Galien Medal for Galafold® (Migalastat)
11/12/2018
First Orphan Drug to Win Prestigious “Innovative Product” Award CRANBURY, N.J. and LONDON, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company focused on discovering, [...]
Alder BioPharmaceuticals® Appoints Carlos Campoy Chief Financial Officer
11/12/2018
BOTHELL, Wash., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
OrthoPediatrics Corp. Announces Closing of Common Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
11/12/2018
WARSAW, Ind., Dec. 11, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the closing of its [...]
Marinus Pharmaceuticals Announces Public Offering of Common Stock
11/12/2018
RADNOR, Pa., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS), (“Marinus” or the “Company”) today announced that it intends to offer and sell 12,000,000 shares of its common stock in an [...]
Tonix Pharmaceuticals Announces Closing of $15,000,000 Public Offering
11/12/2018
NEW YORK, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company focused on developing pharmaceutical products to treat [...]
12 Years of Giving: The Delta Companies Make Significant Donation to Texas Scottish Rite Hospital For Children
11/12/2018
Employees keep the tradition going and raise $144,400 for the hospital DALLAS, Dec. 11, 2018 (GLOBE NEWSWIRE) -- The Delta Companies (TDC), a leading healthcare staffing firm for providers nationwide, announced that its [...]
How to Clean Your Makeup Brushes; American Academy of Dermatology
11/12/2018
ROSEMONT, Ill., Dec. 11, 2018 (GLOBE NEWSWIRE) -- According to dermatologists from the American Academy of Dermatology, dirty makeup brushes can wreak havoc on the skin. In addition to collecting product residue, dirt [...]
NeuroMetrix Reports Agreement with GSK Healthcare on 2019 Quell Joint Development Program and Modification to Strategic Collaboration
11/12/2018
WALTHAM, Mass., Dec. 11, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported momentum in its strategic collaboration with GSK Consumer Healthcare. Under terms of the collaboration entered into in [...]
Align Technology Asserts Ten Additional Patents Against 3Shape
11/12/2018
35 Total Patents Asserted Against 3Shape SAN JOSE, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) today announced that it has filed three additional patent infringement lawsuits [...]
Proposal of candidates to the Board of Directors
11/12/2018
Please read the full announcement in PDF Attachment 2018_67_Proposal of members to the Board of directors_EN
CORRECTION: Athenex Announces Positive Second Cohort Results of Oraxol-plus-Ramucirumab Phase 1b Clinical Trial in Gastric Cancer
11/12/2018
BUFFALO, N.Y., Dec. 11, 2018 (GLOBE NEWSWIRE) -- In a press release issued under the same headline earlier today by Athenex, Inc., please note that the dosing regimen should be “mg/m 2 ,” rather than “mg/kg,” as was [...]

Pages